+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pneumococcal Vaccine"

From
From
Middle East & Africa Vaccines Market Outlook, 2028 - Product Thumbnail Image

Middle East & Africa Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 87 Pages
  • Africa, Middle East
From
Europe Vaccines Market Outlook, 2028 - Product Thumbnail Image

Europe Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 112 Pages
  • Europe
From
North America Vaccines Market Outlook, 2028 - Product Thumbnail Image

North America Vaccines Market Outlook, 2028

  • Report
  • September 2023
  • 101 Pages
  • North America
From
China Human Vaccine Industry Report, 2020-2026 - Product Thumbnail Image

China Human Vaccine Industry Report, 2020-2026

  • Report
  • July 2020
  • 213 Pages
  • China, Global
From
Pneumovax 23 - Product Thumbnail Image

Pneumovax 23

  • Report
  • December 2018
  • 14 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Pneumococcal Vaccine is a type of vaccine used to protect against infection caused by the bacterium Streptococcus pneumoniae. It is used to prevent a range of illnesses, including pneumonia, meningitis, and sepsis. The vaccine is typically administered to infants and young children, as well as adults who are at an increased risk of infection. It is also recommended for adults over the age of 65. The Pneumococcal Vaccine market is a subset of the larger Vaccines market. It is a highly competitive market, with a number of companies offering different types of vaccines. These companies are typically involved in the research, development, and production of the vaccines. They also provide support services such as distribution, marketing, and education. Some of the companies in the Pneumococcal Vaccine market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more